Furthermore, in an orthotopic xenograft model of MDA-MB-231, an aggressive, metastatic human breast cancer cell line, OLN treatment resulted in suppression of GRP78 expression in the tumor, associating with the onset of apoptosis and reduction in tumor load. The gene discussed is HSPA5; the disease is breast carcinoma.